.jpg)
Rebecca Beausang
Regulatory Affairs Specialist, Scilife
Rebecca has over seven years of experience in medical device and other regulated industries. Alongside her expertise in FDA submissions, EU MDR compliance, and ISO 13485 QMS implementation, Rebecca is skilled in creating clear and impactful regulatory content. From technical documentation to compliance blogs, she excels in translating complex topics into engaging, actionable insights. Her passion lies in using compliance as a strategic tool to drive innovation and trust in regulated markets.
As of February 2, 2026, the transition period for the Quality Management System Regulation (QMSR) has officially ended. The FDA now expects full compliance with this new framework, guaranteeing that FDA 21 CFR part 820 and ISO 13485 operate as one.
Subscribe to the
Scilife Blog
Life Science and Quality resources and news. All directly to your inbox!
